Medytox Venture Investment
Seoul, Seoulmedytoxventure.com
Overview
Medytox Venture Investment is the corporate venture capital arm of Medytox, a biopharmaceutical company based in Seoul, South Korea. Founded in 2017, the firm actively invests in early-stage biotechnology and healthcare companies. Its investment focus includes new drug development, medical devices, diagnostics, cosmeceuticals, and functional foods, seeking to create synergies with its parent company. The firm is also an operator for the TIPS (Tech Incubator Program for Startup) program in Korea, which supports tech startups.
Portfolio Companies
10
Website
medytoxventure.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NEX-I, Inc. | Aug 2025 | Series B | Co-investor |
| Aigen Sciences | Oct 2024 | Series A | Co-investor |
| Avelos Therapeutics | Apr 2024 | Series B | Co-investor |
| GPCR Therapeutics | Nov 2023 | Series C Extension | Co-investor |
| Ubix Therapeutics | Jul 2023 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
